What must a Wegovy letter of medical necessity include?

A strong letter should include patient demographics, current BMI with measurement date, ICD-10 diagnosis code (E66.01 or E66.9 with comorbidity), documented weight history, list of failed prior therapies with dates and outcomes, relevant comorbidities with lab values, clinical rationale for Wegovy specifically, and the prescriber's NPI with signature. It must directly address the denial reason on your letter — not just state that the patient needs the medication.

Can I write my own letter of medical necessity for Wegovy?

You can draft supporting materials, but insurers require a signed letter from a licensed prescriber — typically your obesity medicine physician, endocrinologist, or primary care provider. Patient-written letters alone are almost always denied. Provide your doctor a bullet-point summary of failed therapies, comorbidities, and the specific denial code so they can write a targeted clinical letter.

How long should a Wegovy medical necessity letter be?

One to two pages is ideal. Shorter than one page often lacks the clinical detail insurers require. Longer than three pages risks burying the key arguments. Focus on dated metrics, ICD-10 codes, and step therapy documentation rather than general statements about obesity.

Does my doctor submit the letter through CoverMyMeds or Express Scripts?

It depends on your PBM. Many prescribers submit initial prior auths through CoverMyMeds, but formal appeals after denial may require upload to Express Scripts, OptumRx, or Caremark member portals. Ask your doctor's office which portal they use and confirm the letter was attached before your appeal deadline.

What ICD-10 code should appear on a Wegovy medical necessity letter?

For chronic weight management, use E66.01 (morbid obesity due to excess calories) or E66.9 (obesity, unspecified) with documented comorbidities. Do not use E11.x diabetes codes unless your plan has a separate diabetes GLP-1 pathway. A code mismatch between the letter and the prior auth request is a frequent cause of automatic denial.

Can I reuse a medical necessity letter from a different GLP-1 medication?

No. Each drug has distinct FDA indication criteria and NDA numbers. If you are switching from Saxenda to Wegovy or appealing a Wegovy-specific denial, the letter must cite Wegovy (semaglutide 2.4 mg, NDA 215256) and explain why this formulation is clinically appropriate — not just copy a template written for another medication.

What if my doctor refuses to write a detailed medical necessity letter?

Ask for a peer-to-peer review instead — your prescriber speaks directly with the insurer's medical director. If your doctor's office lacks prior auth staff, consider switching to a provider experienced with GLP-1 appeals, or use AppealFlow's GLP-1 generator to draft a formal appeal letter you can bring to your next appointment for review and signature.

How soon after a denial should the medical necessity letter be submitted?

As soon as possible — ideally within two weeks of receiving the denial. ERISA plans allow 180 days, but delays mean more weeks without medication. Expedited appeals require the prescriber to certify that waiting poses a serious health risk, which must appear in the letter itself.

Sample Letter of Medical Necessity for Wegovy (Free Download)

By Medical Claims Advocacy Team•13 min read•Updated July 2026

A Wegovy letter of medical necessity must be written and signed by your prescribing physician — not copied from a generic online template. The letter needs your BMI with measurement date, ICD-10 obesity codes, documented step therapy failures, comorbidity records, and a direct response to your specific denial reason. Bring this sample structure to your doctor's office to speed up the process.

What Insurers Require in a Wegovy Medical Necessity Letter

Key Takeaway: Insurer medical directors approve letters with dated clinical metrics — not emotional appeals. Your prescriber must address the exact denial code, cite FDA Wegovy indication criteria (NDA 215256), and document every required step therapy with dates and outcomes.

After reviewing hundreds of GLP-1 prior auth packets, I can tell you the letter of medical necessity is the single document that determines approval or denial. A one-paragraph note saying “patient needs Wegovy” gets rejected roughly 90% of the time.

Insurers evaluate letters against their internal pharmacy criteria — which mirror FDA labeling but add step therapy, BMI thresholds, and documentation requirements. Your letter must hit every checkbox:

Patient identifiers: Full name, date of birth, member ID, and prescription date
Clinical measurements: Height, weight, BMI with date of measurement (within 90 days)
Diagnosis: ICD-10 E66.01 (morbid obesity) or E66.9 with documented comorbidities
Comorbidities: Hypertension (I10), prediabetes (R73.03), OSA (G47.33), dyslipidemia (E78.5) — with supporting lab values where available
Step therapy history: Each required therapy with start/end dates, dose, duration, and outcome
Clinical rationale: Why Wegovy specifically meets FDA criteria for this patient
Prescriber credentials: Name, specialty, NPI, office address, phone, and signature

Step-by-Step: Getting Your Doctor to Write the Letter

Key Takeaway: Do not wait for your doctor to initiate the letter. Bring a prepared clinical summary, your denial letter, and this template structure to your appointment or portal message. Most approvals happen when patients do the prep work and the prescriber signs off.

Pull your denial letter and note the reason code. Step therapy (PA-STEP), formulary exclusion (FORM-EXCL), or insufficient documentation (DOC-INSUF) each require different letter language.
Create a one-page clinical summary for your doctor. List BMI history, comorbidities with dates, every weight-loss therapy tried, and outcomes. Your doctor's office can convert this into a formal letter faster than starting from scratch.
Request the letter on letterhead with NPI. Insurers reject letters without NPI numbers or on plain paper without practice identification.
Ask your prescriber to address the denial code explicitly. “This letter responds to denial code PA-STEP-01 and documents satisfaction of step therapy requirements per plan Section 4.2.”
Review the draft before submission. Check that dates, BMI, and ICD-10 codes match your prior auth request exactly. Mismatches trigger automatic re-denial.
Submit through the correct PBM portal. CoverMyMeds, Express Scripts, OptumRx, or Caremark — confirm receipt before your deadline.

Sample Wegovy Letter of Medical Necessity (Template)

Key Takeaway: Replace every bracketed placeholder with your actual clinical data. Your prescriber must review, modify as clinically appropriate, sign, and date the final version. This is a structural guide — not a document you can submit as-is.

[Prescriber Name, MD/DO]

[Practice Name] | NPI: [NPI Number]

[Address] | [Phone]

[Date]

Re: Letter of Medical Necessity — Wegovy (semaglutide 2.4 mg)

Patient: [Full Name] | DOB: [Date] | Member ID: [ID]

I am writing to establish medical necessity for Wegovy (semaglutide 2.4 mg subcutaneous injection) for the above-named patient, who meets FDA-approved indication criteria for chronic weight management (NDA 215256).

Diagnosis: Morbid obesity (ICD-10 E66.01). Current BMI: [XX.X] measured on [date]. Weight history: [starting weight] → [current weight] over [timeframe].

Weight-related comorbidities: [Hypertension I10 — BP [value] on [date]; Prediabetes R73.03 — HbA1c [value]% on [date]; Obstructive sleep apnea G47.33 — diagnosed [date]].

Prior weight-loss interventions (step therapy):

Intensive lifestyle modification: [dates], outcome: [weight change or % loss]
Metformin [dose]: [dates], discontinued due to [intolerance/insufficient response]
Phentermine [dose]: [dates], discontinued due to [tachycardia/insufficient response]

Clinical rationale: Patient has failed required step therapies per plan criteria. Wegovy is indicated for chronic weight management in adults with BMI ≥30, or ≥27 with weight-related comorbidity. Expected clinical benefit includes reduction in cardiovascular risk factors and improvement in metabolic parameters.

I respectfully request approval of Wegovy 2.4 mg with a [12-month] treatment duration. Please contact my office at [phone] for additional records.

Sincerely,

[Prescriber Signature]

[Prescriber Name, MD/DO] | NPI: [Number]

Weak vs. Strong Medical Necessity Language (Before & After)

Key Takeaway: Replace vague clinical statements with dated metrics, ICD-10 codes, and FDA criteria references. Insurer reviewers process dozens of letters daily — specificity is what separates approved from denied.

❌ Weak Statement	✅ Strong Statement
“Patient is obese and would benefit from Wegovy.”	“Patient (BMI 33.8, E66.01, measured 06/15/2026) has hypertension (I10, BP 148/92) and prediabetes (HbA1c 6.1%, R73.03). Meets FDA Wegovy criteria per NDA 215256 for BMI ≥27 with weight-related comorbidity.”
“Patient tried diet and exercise without success.”	“Patient completed 6 months of registered dietitian-supervised program (01/2026–06/2026) with documented weight loss of 3 lbs (1.2% body weight). Metformin 1000mg BID × 90 days discontinued due to persistent nausea and vomiting per visit note 05/12/2026.”
“Please approve Wegovy for this patient.”	“This letter addresses denial code PA-STEP-01. All required step therapies per plan formulary Section 4.2 have been completed with documented failure. I request formulary exception and prior authorization approval for Wegovy 2.4 mg × 12 months.”

Need a Complete Wegovy Appeal Packet?

AppealFlow's GLP-1 generator drafts a formal appeal letter with medical necessity language, step therapy documentation, and ERISA rights — ready for your prescriber to review in under 60 seconds.

Generate GLP-1 Appeal Letter

Comorbidity Documentation That Strengthens Your Letter

Key Takeaway: If your BMI is between 27 and 30, comorbidity documentation is mandatory — not optional. Insurers will deny without objective evidence of at least one weight-related condition beyond obesity itself.

For patients with BMI ≥30, comorbidities strengthen the letter but are not always required. For BMI 27–29.9, at least one documented comorbidity is essential under FDA labeling and most plan criteria.

Hypertension (I10): Two BP readings above 130/80 on separate dates
Prediabetes (R73.03): HbA1c 5.7–6.4% or fasting glucose 100–125 mg/dL
OSA (G47.33): Sleep study results or CPAP prescription
Dyslipidemia (E78.5): LDL above goal despite statin therapy
PCOS (E28.2): Diagnosis with metabolic markers

Attach lab results directly to the appeal packet — do not rely on the letter alone to reference values your insurer cannot verify.

Submitting Through PBM Portals (CoverMyMeds, Express Scripts, OptumRx)

Key Takeaway: The letter must be attached to a formal appeal — not just uploaded to an initial prior auth request. After denial, the appeal process has different legal protections and submission channels.

Platform	Used By	Letter Submission
CoverMyMeds	Multiple PBMs; prescriber-initiated	Provider uploads letter via key code; attach as appeal supporting doc
Express Scripts	Cigna, some BCBS plans	Member portal → Pharmacy → Appeals → Upload Documents
OptumRx	UnitedHealthcare, employer plans	OptumRx.com → Prior Authorization → File Appeal → Attach letter
Caremark (CVS)	Aetna, CVS Health plans	Caremark.com → Coverage & Claims → Appeal → Upload medical necessity letter

After uploading, call member services to confirm the letter was received and linked to your appeal case number. Portal uploads sometimes fail silently — a phone confirmation takes five minutes and prevents deadline disasters.

Realistic Success Rates and Timelines

Key Takeaway: Letters with complete clinical documentation succeed roughly 45–55% on first internal submission. Generic one-paragraph letters succeed less than 10%. Plan for 30 days for standard review, 72 hours for expedited appeals.

I want to be honest: even a perfect letter does not guarantee approval if your plan excludes GLP-1 weight-loss drugs entirely. In that case, you need a formulary exception request — a different process with different criteria.

Standard appeal with complete letter: 30 days for insurer response
Expedited appeal: 72 hours — prescriber must certify urgent medical need in the letter
External review after internal denial: 45–60 additional days

Common mistake: Using a letter written for Ozempic (diabetes indication) for a Wegovy (obesity) appeal. The FDA indications, doses, and ICD-10 codes are different. Your letter must reference Wegovy specifically.

Five Mistakes That Invalidate Medical Necessity Letters

Key Takeaway: A strong letter attached to a weak appeal process still fails. Avoid these documentation errors that cause automatic denials regardless of clinical merit.

Missing NPI or signature. Unsigned letters are returned without review.
Outdated BMI. Weight measurements older than 90 days are frequently rejected.
Wrong ICD-10 code. E11.x diabetes codes on a weight management appeal trigger automatic denial on most plans.
No response to denial reason. Generic letters that ignore the specific denial code get treated as new prior auth requests, not appeals.
Submitting without the appeal form. The letter supports a formal appeal — it does not replace the appeal filing itself.

Frequently Asked Questions

Answers to the most common questions about Wegovy letters of medical necessity.

Generate Your Free Wegovy Appeal Letter

AppealFlow.net drafts a formal appeal with medical necessity language, step therapy documentation, and ERISA rights — edit live, then download as PDF or Word. No account required.

Generate Free Appeal Letter GLP-1 Specialized Tool

100% Free
No Signup
PDF & Word Export

Disclaimer: This article is for educational purposes only and does not constitute medical or legal advice. AppealFlow.net is not a healthcare provider or law firm. Success rates cited are estimates based on industry advocacy data and vary by plan. Always review appeal letters with your prescriber before submission. For medical emergencies, call 911. See our full disclaimer.